Obermatt

Samsung Pharm

KSC:001360 · KR7001360007
PharmaceuticalsSmall

360° View

no current rank
Price/Sales13
Price/Earnings97
Price/Book46
Dividend Yield1
Revenue Growth6
Profit Growth14
Capital Growth75
TSR 52w43
Leverage51
Liquidity12
Refinancing44
Combined16
Analyst Opinions
Pro Holdings24
Opinion Changes
Market Pulse6

Profile

CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeKOSE
ISINKR7001360007
Last UpdateApr 2, 2026
Index & Theme
NeurologyGastroenterologyChronic DiseasesHepatologyNutraceuticalHealth CareManufacturingMedicalPharmaceutical

Description

Similar Stocks

The companies this stock is ranked against.

Compare Samsung Pharm with its peers
PharmGen Science
KSC:004720
74
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Hana Pharm
KSC:293480
88
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
SD Biosensor
KSC:137310
15
CountrySouth Korea
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Reyon Pharmaceutical
KSC:102460
16
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Kukje Pharma
KSC:002720
43
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Kyongbo Pharmaceutical
KSC:214390
11
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →